Cost-effectiveness of Telemedicine-directed Specialized vs Standard Care for Patients With Inflammatory Bowel Diseases in a Randomized Trial
- 23 April 2020
- journal article
- research article
- Published by Elsevier BV in Clinical Gastroenterology and Hepatology
- Vol. 18 (8), 1744-1752
- https://doi.org/10.1016/j.cgh.2020.04.038
Abstract
No abstract availableKeywords
Funding Information
- Maastricht University Medical Centre+ (31962340B)
- Ferring BV
This publication has 28 references indexed in Scilit:
- Telehealth in Inflammatory Bowel Disease: Every Patient May Need a Coach!Gastroenterology, 2018
- TelehealthNew England Journal of Medicine, 2017
- Evolution of Costs of Inflammatory Bowel Disease over Two Years of Follow-UpPLOS ONE, 2016
- Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current managementJournal of Crohn's and Colitis, 2012
- Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNFα therapy: results from the COIN studyGut, 2012
- How should we define health?BMJ, 2011
- The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current managementJournal of Crohn's and Colitis, 2010
- What is the peak age for onset of IBD?Inflammatory Bowel Diseases, 2008
- Health-related Quality of Life in Patients with Inflammatory Bowel Disease Measured with the Short Form-36: Psychometric Assessments and a Comparison with General Population NormsInflammatory Bowel Diseases, 2005
- Cost of illness of inflammatory bowel disease in the UK: a single centre retrospective studyGut, 2004